Lavender Lane Opens in Noida, Built on a Simple Idea — A Child Is Not a Small Adult

▴ Dr. Silky Jain, one of the country’s leading paediatric haemato-oncologists and bone marrow transplant physicians
India’s first paediatric super-speciality centre, founded by Dr. Silky Jain and backed by a Singapore-based family office, brings every speciality under one calm roof. Opening July 2026.
Delhi NCR, June 12, 2026 — Lavender Lane, India’s first paediatric super-speciality care centre, today announced the launch of its flagship facility in Sector 90, Noida, opening July 2026. It is built on a single principle the healthcare system too often forgets — a child is not a small adult. Conceived and founded by Dr. Silky Jain, one of the country’s leading paediatric haemato-oncologists and bone marrow transplant physicians, Lavender Lane reimagines how serious and everyday childhood illnesses are treated: around the child, rather than around the system.
The mission behind Lavender Lane is personal and hard-won. Dr. Jain spent fifteen years as a practising paediatric haemato-oncologist, sitting across the table from families on the worst day of their lives — and watching the system compound their difficulty. Parents became their own case managers, shuttling between departments, translating five different specialists’ opinions into a single plan, often sleeping on hospital chairs for weeks while their child received treatment that research had long established could be safely delivered in a day-care setting. Lavender Lane was built to answer one question those families always asked: why does this have to mean weeks inside a hospital? The mission is to give every child in India — and every family around that child — a fundamentally different experience of care: specialist, coordinated, compassionate, and built from the ground up around small humans.
The need: care built for adults, then adapted for children
Most places Indian families take their children for serious care were designed for adults first and adapted for children later. Children’s wards are wings inside adult hospitals — the same lighting, the same corridors, the same fragmented coordination that leaves a parent shuttling between five departments whose specialists might not have spoken to one another.
For a healthy child with a routine illness, that is an inconvenience. For a child with a serious or chronic condition, it can mean weeks living inside a hospital, parents sleeping on chairs, depriving them of their childhood and parenthood.
“A child is not a miniature adult, and medicine often forgets this fact” said Dr. Silky Jain, Founder of Lavender Lane. “I spent over a decade inside that system and sat across the table from several parents on the worst day of their lives. Lavender Lane is what I built when I stopped accepting that this was the only way. Because every child deserves special care, delivered in the best possible way! ”
A different model: four ideas, one roof
Lavender Lane is organised around four founding commitments:
Every speciality under one roof. Paediatric haemato-oncology, pulmonology, neurology, gastroenterology, endocrinology, cardiology, nephrology, developmental-behavioural paediatrics, and more — with in-house diagnostics and an on-site paediatric pharmacy, so a child never needs to leave the building for the next step in their care.
One team around one family. A senior specialist leads each child’s care. Where multiple specialities are involved, they speak to one another before they speak to the family — so parents hear one plan, not five competing opinions. A dedicated care navigator stays with the family from the first call to the last follow-up.
Day-care first, wherever it’s safe. Chemotherapy, transfusions, infusions, and monitored procedures are delivered in a calm day-care setting wherever clinically appropriate — so children receive advanced treatment and still sleep in their own beds.
Spaces built for small humans. The building is designed from the floor up around what a child needs — soft light, quiet corners, play areas woven into the clinical space, and a lobby built so the first thirty seconds of arrival don’t spike a child’s anxiety. Design, here, is a clinical decision.
The founder
Dr. Silky Jain is a senior paediatric haemato-oncologist and bone marrow transplant physician, trained at Maulana Azad Medical College Delhi, the Rajiv Gandhi Cancer Institute, and Great Ormond Street Hospital London, with fifteen years of practice across India’s leading paediatric programmes.
Her conviction is simple and hard-won: the child is the one with the diagnosis, but the illness happens to a household — so a paediatrician treats the family around the child.
Backing and vision
Lavender Lane is funded by a Singapore-based family office that shares its long-term vision: to fundamentally change the experience of childcare in India, beginning with the National Capital Region: the Noida flagship at Bhutani Alphathum, Sector 90.
“Our vision is to build the kind of place a parent would want on an ordinary Tuesday and on the worst day of their lives, both,” added Dr. Jain. “Less time in hospitals. More time being kids.”
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-






Trending Now

Healthcare Leaders Share Industry Insights Shaping IndiaJuly 04, 2026
Warning Signs Your Body Gives Before Serious IllnessJuly 04, 2026
Diabetes Prevention Tips for Indians: A Practical GuideJuly 03, 2026
Superbugs and Global Health: India's Growing AMR CrisisJuly 03, 2026
Navigating a New Cancer Diagnosis: Oncologists & Pathways July 02, 2026
Skin Allergies in the Monsoon: Common Triggers and TreatmentsJuly 02, 2026
The Growing Problem of Antibiotic Resistance in IndiaJuly 02, 2026
Future of Healthcare in India: Doctors on AI and CareJuly 02, 2026
High Blood Pressure: Causes, Symptoms and Prevention GuideJuly 02, 2026
CARE Hospitals Celebrates National Doctors' Day, Honours Doctors for Their Commitment to Saving LivesJuly 01, 2026
Ancient Wisdom Meets Modern Science at Happiest Health’s ‘Ayurveda & Gut’ EventJuly 01, 2026
Estrogen Replacement Therapy Market Size to Reach USD 19.4 Billion by 2034 at a 5.7% CAGR from 2026 to 2034July 01, 2026
MGM Healthcare and MGM Cancer Institute announced an exclusive Master Health and Vaccination Package for Blood Donors.July 01, 2026
QR678® Enters European Market with Germany as Strategic Launchpad for QR678 X-PRO®July 01, 2026
Patient Experience in Healthcare: Why It Matters in IndiaJuly 01, 2026
Antibiotic Resistance in India: Causes, Risks and SolutionsJuly 01, 2026
The Truth About Antibiotics: Why You Should Never Self-Medicate July 01, 2026
The Role of Microbiome in Gut Health and ImmunityJuly 01, 2026
Understanding Autoimmune Diseases: Why Your Body Attacks Itself July 01, 2026
Thyroid Cancer: Early Signs, Diagnosis, and Treatment in IndiaJuly 01, 2026